(Q46979280)

27 December 2017

title

Effectiveness of Factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage (English)

1 reference

27 December 2017

blood coagulation disease

1 reference

1 reference

Farhan Siddiq

1

1 reference

27 December 2017

Abdul Jalil

2

1 reference

27 December 2017

Cara McDaniel

3

1 reference

27 December 2017

David G Brock

4

1 reference

27 December 2017

Carissa C Pineda

5

1 reference

27 December 2017

Rodney D Bell

6

1 reference

27 December 2017

Kiwon Lee

7

1 reference

27 December 2017

publication date

1 January 2008

1 reference

27 December 2017

published in

Neurocritical Care

1 reference

27 December 2017

volume

8

1 reference

27 December 2017

issue

1

1 reference

27 December 2017

page(s)

36-41

1 reference

27 December 2017

https://scigraph.springernature.com/pub.10.1007/s12028-007-9011-5

exact match

0 references

cites work

Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.

1 reference

https://api.crossref.org/works/10.1007%2FS12028-007-9011-5

Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-007-9011-5

Emergency reversal of anticoagulation after intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-007-9011-5

Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-007-9011-5

Anaphylactic transfusion reactions

21 January 2018

1 reference

12 December 2020

Managing oral anticoagulant therapy

1 reference

12 December 2020

Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy

1 reference

12 December 2020

Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, Minnesota

1 reference

12 December 2020

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy

1 reference

12 December 2020

Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.

1 reference

12 December 2020

Advances in intracerebral hemorrhage management

1 reference

12 December 2020

Use of factor IX complex in warfarin-related intracranial hemorrhage

1 reference

12 December 2020

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis

1 reference

12 December 2020

The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings

1 reference

12 December 2020

Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions

1 reference

12 December 2020

Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid

1 reference

12 December 2020

Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment

1 reference

12 December 2020

Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrat

1 reference

12 December 2020

Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.

1 reference

12 December 2020

The increasing incidence of anticoagulant-associated intracerebral hemorrhage

1 reference

12 December 2020

Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage

1 reference

12 December 2020

1 reference

12 December 2020

Potential applicability of recombinant factor VIIa for intracerebral hemorrhage

1 reference

12 December 2020

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

1 reference

12 December 2020

Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies

1 reference

12 December 2020

1 reference

12 December 2020

Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin

1 reference

12 December 2020

Long-term mortality after intracerebral hemorrhage

1 reference

12 December 2020

Management of anticoagulation before and after elective surgery

1 reference

12 December 2020

Guideline for the use of fresh-frozen plasma. Medical Directors Advisory Committee, National Blood Transfusion Council

1 reference

12 December 2020

Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.

1 reference

12 December 2020

Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors

1 reference

12 December 2020

Hypocalcemic toxicity and atypical reactions in therapeutic plasma exchange

1 reference

12 December 2020

Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.

1 reference

12 December 2020

Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage.

1 reference

12 December 2020

The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage

1 reference

12 December 2020

Acquired immunodeficiency syndrome (AIDS) associated with transfusions.

1 reference

12 December 2020

Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis

1 reference

12 December 2020

Treating warfarin-related intracerebral hemorrhage: is fresh frozen plasma enough?

1 reference

12 December 2020

Recombinant activated factor VII for acute intracerebral hemorrhage.

1 reference

12 December 2020

Virus safety of prothrombin complex concentrates and factor IX concentrates

1 reference

12 December 2020

10.1007/S12028-007-9011-5

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017